Kanamycin Concentration Reduction During the VGXI Process

Download White Paper

Name*
First Last
Email*
Phone*
Company or Institution*
Message
How did you hear about VGXI?
CAPTCHA

Kanamycin is widely used as a selection mechanism during production of plasmid DNA for vaccines and gene therapy products. This white paper details how the concentration of Kanamycin is reduced during the VGXI downstream purification process.

> Kanamycin Concentration Reduction During the VGXI Process

Kanamycin Concentration Reduction During the VGXI Process

Download White Paper

Get In Touch

VGXI, INC.

281-296-7300